Client News
Galimedix appoints Dr. Luciana Summo as Vice President, R&D Operations
25th October 2023
Abivax announces Closing of its Initial Public Offering on the Nasdaq Global Market
24th October 2023
Carbios Places Sustainability at the Heart of its Governance with New Appointment to its Executive Committee
23rd October 2023
Abivax announces trading resumption of its ordinary shares on Euronext Paris
20th October 2023
Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market
20th October 2023
Abivax announces temporary trading halt of its ordinary shares on Euronext Paris
20th October 2023
Abivax announces the filing of an amended registration statement, including an estimated initial public offering price range
19th October 2023
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
18th October 2023
Secarna Pharmaceuticals to present two posters showcasing the innovation potential of the LNAplus platform at the 19th Annual Meeting of the Oligonucleotide Therapeutic Society
17th October 2023
Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing
16th October 2023
There is no more content to load